BioCentury
ARTICLE | Clinical News

Provigil Phase III data

October 9, 2001 7:00 AM UTC

Cephalon (CEPH) said its Provigil modafinil oral non-dopaminergic alpha adrenergic stimulant increased daytime wakefulness in patients with obstructive sleep apnea who use a device to provide continuo...